Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451379) titled 'Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver Transplant' on Feb. 28.

Study Type: Observational

Primary Sponsor: Assiut University

Condition: Non-invasive Donor Liver Assessment

Recruitment Status: Not recruiting

Date of First Enrollment: July 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07451379

Published by HT Digital Content Services with permission from Health Daily Digest....